Pediatrix Medical Group insider Linynsky Laura A disposed of 6,000 shares at $26.82 per share on 2026-09-10. The transaction represented about 15.0% of her prior holding and left her with 33,900 shares, giving investors a specific view of the reported change in her ownership position.
Key Highlights
- The transaction carried SEC transaction code D.
- Pediatrix Medical Group, Inc. was identified as the company connected to the insider transaction.
- Linynsky Laura A disposed of 6,000 Pediatrix Medical Group shares at $26.82 per share on 10 September 2026.
Pediatrix Medical Group (NYSE: MD) insider Linynsky Laura A disposed of 6,000 shares at $26.82 per share on 10 September 2026.
Transaction Details and Remaining Holding
The disclosure ties the transaction to Pediatrix Medical Group and identifies Linynsky Laura A as the individual involved. The stated post-transaction figure covers her remaining shares following the disposition.
Reported Change in Insider Ownership
The disposition represented about 15.0% of Linynsky Laura A’s prior shares holding. The remaining reported position was 33,900 shares after the transaction. The percentage provides the stated comparison between the transaction and her earlier holding.
FAQs
Q: What did Linynsky Laura A’s Pediatrix insider transaction involve?
A: Linynsky Laura A disposed of 6,000 Pediatrix Medical Group shares at $26.82 per share on 10 September 2026. The transaction used SEC code D.
Q: How many Pediatrix shares did Linynsky Laura A retain?
A: Linynsky Laura A held 33,900 Pediatrix Medical Group shares after the insider transaction. The disposition represented about 15.0% of her prior shares holding.
Q: What was the price of the Pediatrix insider transaction?
A: The reported Pediatrix Medical Group transaction was priced at $26.82 per share. Linynsky Laura A disposed of 6,000 shares in the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.